Net Sales, Gross Margins and Operating Expenses on Track
Consumption Numbers up 27% on 52-week Data
Stryve Nutrition Portfolio Exited as Part of Rationalization
PLANO, Texas, Feb. 16, 2023 (GLOBE NEWSWIRE)
Delix Nabs 2 New Partners
Neuroscience company Delix Therapeutics is partnering with Sweden-based Cellectricon and New York-based Expressive Neuroscience.
The goal is to expedite Delix's drug development pipeline.